about
Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women.Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.Enrolment of young adolescents in a microbicide acceptability study.Preferred methods of sexually transmitted infection service delivery among an urban sample of underserved midwestern men.Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study.The role of herd immunity in parents' decision to vaccinate children: a systematic review.Parent-son decision-making about human papillomavirus vaccination: a qualitative analysisUse of drawings to explore U.S. women's perspectives on why people might decline HIV testingVaccinating sons against HPV: results from a U.S. national survey of parents.Educational interventions to increase HPV vaccination acceptance: a systematic review.The effects of vaccine characteristics on adult women's attitudes about vaccination: a conjoint analysis studyThe impact of brief messages on HSV-2 screening uptake among female defendants in a court setting: a randomized controlled trial utilizing prospect theory.Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.Adolescent decision making about participation in a hypothetical HIV vaccine trialThe influence of resuscitation preferences on obstetrical management of periviable deliveries.Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists.Can self-prediction overcome barriers to Hepatitis B vaccination? A randomized controlled trialWillingness to receive an HIV vaccine among incarcerated personsHPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents.Attitudes towards microbicide use for bacterial vaginosis in pregnancy.Acceptability of HPV vaccine implementation among parents in India.Risk perceptions, sexual attitudes, and sexual behavior after HPV vaccination in 11-12 year-old girls.School-based HPV immunization of young adolescents: effects of two brief health interventionsRisk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women.Human Papillomavirus Vaccine Initiation among 9-13-Year-Olds in the United States.Understanding and overcoming barriers to human papillomavirus vaccine acceptance.Chapter 24: Psychosocial aspects of vaccine acceptability.Preventive misconception and adolescents' knowledge about HIV vaccine trials.The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infectionAppropriate use of cervical cancer vaccine.Human papillomavirus vaccine and adolescents.Research on adolescents and microbicides: a review.Literature review of human papillomavirus vaccine acceptability among women over 26 years.Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women.Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents.Recommendations for a national agenda to substantially reduce cervical cancer.HPV vaccine and males: issues and challenges.Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey.Behavioral considerations for engaging youth in HIV clinical research.Human papillomavirus vaccine and men: what are the obstacles and challenges?
P50
Q30988794-6E011AFD-800E-412E-8DEC-FE01F857BF98Q33940778-B15B68DF-5522-4B9F-8F70-1A17FC0A4D72Q33988538-3F0D66E5-7C32-44EF-9FF0-8D24666F18FCQ34103920-10B64024-2584-40E3-9ABA-B2C0CA0B36D2Q34288129-7C6EB370-BBE8-40C2-BDDF-D0646108F05FQ34296277-DA31AC51-C83E-4826-9042-E4D4B97356C6Q34513098-775CED77-D3D4-4037-BCB6-668DA2C6DE2EQ34769608-8695BC84-EACF-4742-8DB7-0DC839168C43Q34775910-A0806DCB-C4FE-4ECD-A80C-3F49CD0EE8B4Q34846745-959752A0-53A7-414F-BDF8-4F249E348414Q35056756-4301B1AD-8232-4742-9C4F-CC992F7C5E2CQ35168121-CE2648E2-345A-4C78-9D96-8764DD1F57ABQ35230239-0EEA344F-0B0B-4B18-B8C0-9B2111657E7AQ35232408-A395C704-C35B-422D-A92C-6780F19740D9Q35552426-17151698-46A7-460D-B6B6-BD89717B67E2Q35614621-506DFC29-B923-4A5D-99FC-192603AFAEF9Q35629369-DF023811-FA3D-477F-9628-2A318EFB56C9Q35644871-0C62E47D-E05D-420E-AF89-EEFC366A0797Q35776619-97866EAD-3F5B-4BCC-8BCD-938148F28FDFQ35786275-DF377999-A172-441E-B21A-DC6CF1166152Q35854649-12099F4A-E319-4EDA-AA0A-DE83891421BDQ35875491-CAD009D7-1B98-4521-B644-0967A898F17EQ35886808-AD4E331C-9E7B-4250-B159-24DE09B4200CQ35911745-2B57313E-FB88-4889-BEA6-D4C154D955A1Q36298355-4F8C7CA3-4D39-440A-A215-149F86F9A3C4Q36415250-50A9322B-F326-4773-BDED-2BAA9AE9D3BBQ36584387-EB5A303A-862A-4A5A-9239-1B7A5F105DBCQ36917016-120B6321-5141-4698-A137-0290F4AAA13FQ36930407-76DF26C2-C56D-4F19-8D67-FF83CFE8B010Q37054397-6B391030-8FE2-4981-9B96-DBFC5D922257Q37271299-D9C062E5-BE5A-4579-BCB9-C8F80B2A1402Q37336226-60CDC151-FEC5-4AF4-85D6-7048282E6F0BQ37386019-F286DAD1-35A6-40AF-951C-BC0B7A94A052Q37399223-C0C81977-B783-4BB2-8457-AE9280F5678AQ37602506-9DE01F4B-782F-4A23-BB8E-83616DD2DA72Q37677381-4267A7B3-ED58-401A-B12D-205C11FA99A8Q37686833-819EDE9C-48D1-47C2-BC7A-48EE273D80D1Q37716012-5FAE771E-33E4-47EA-832F-B58701DBF810Q37767126-19A6DEDE-3EAD-44EF-9AF6-0ADB62E02EB2Q37964932-5BE1A45C-5785-4694-BCCB-E8B3595BC856
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gregory D Zimet
@nl
Gregory D Zimet
@sl
Gregory D. Zimet
@en
Gregory D. Zimet
@es
type
label
Gregory D Zimet
@nl
Gregory D Zimet
@sl
Gregory D. Zimet
@en
Gregory D. Zimet
@es
prefLabel
Gregory D Zimet
@nl
Gregory D Zimet
@sl
Gregory D. Zimet
@en
Gregory D. Zimet
@es
P106
P1153
7003441652
P21
P31
P496
0000-0003-3835-937X